IFG Advisory LLC Boosts Johnson & Johnson Stake by 54.7%

Institutional investor increases holdings in pharmaceutical giant

Mar. 5, 2026 at 12:20pm

Got story updates? Submit your updates here. ›

IFG Advisory LLC, an investment management firm, grew its stake in Johnson & Johnson (NYSE:JNJ) by 54.7% in the third quarter, according to a recent SEC filing. The fund now owns 38,902 shares of the company's stock, worth approximately $7.2 million as of the most recent reporting period.

Why it matters

Johnson & Johnson is a bellwether pharmaceutical company, and changes in institutional ownership can signal broader market sentiment around the stock. IFG Advisory's increased stake suggests confidence in J&J's long-term prospects, even as the company faces some legal challenges and mixed analyst sentiment.

The details

According to the 13F filing, IFG Advisory acquired an additional 13,760 shares of Johnson & Johnson during the third quarter, bringing its total position to 38,902 shares. This represents a 54.7% increase in the firm's holdings of the stock. Johnson & Johnson is a diversified healthcare company with a focus on pharmaceuticals, medical devices, and consumer products.

  • IFG Advisory LLC filed its 13F report for the third quarter of 2026 on March 5, 2026.

The players

IFG Advisory LLC

An investment management firm that provides financial advisory services.

Johnson & Johnson

A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

The takeaway

The increase in IFG Advisory's stake in Johnson & Johnson suggests institutional confidence in the company's long-term growth potential, despite some near-term challenges. As a bellwether stock, J&J's performance is closely watched by investors and analysts alike.